This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.00% per year. These returns cover a period from January 1, 1988 through May 4, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
insurance: Archive
New Strong Sell Stocks for Dec. 18
by Zacks Equity Research
AVVIY, CLMB and CLCO have been added to the Zacks Rank #5 (Strong Sell) List on Dec. 18, 2025.
insurance
New Strong Buy Stocks for Dec. 18: MTLS, AMX, and More
by Zacks Equity Research
JRVR, CALX, MTLS, AMX and NWFL have been added to the Zacks Rank #1 (Strong Buy) List on Dec. 18, 2025.
communications insurance
5 Insurance Stocks That Can Be Secure Investments for 2026
by Tanuka De
TRV, AXS, JXN, LNC and GL have outperformed in 2025 and look set to deliver strong returns in 2026 too.
insurance
Do Options Traders Know Something About First American Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to FAF stock based on the movements in the options market lately.
insurance
Health Insurers Now Get a Pulse: 3 Stocks to Jump in 2026
by Kaibalya Pravo Dey
Health insurers are regaining pricing control and margin visibility, putting UnitedHealth, CVS Health and Centene back in focus as managed care regains its pulse.
insurance medical
New Strong Buy Stocks for Dec. 17: FG, LSPD, and More
by Zacks Equity Research
FG, APH, LSPD, ALLT and BFH have been added to the Zacks Rank #1 (Strong Buy) List on Dec. 17, 2025.
computers insurance
Berkshire Hathaway vs. MetLife: Which Insurance Giant Stands Out?
by Tanuka De
BRK.B and MET remain resilient amid rate cuts and rising climate risks, but one outpaces the other in terms of ROE and growth.
insurance
Tech Innovations to Power Lemonade's Scalable Insurance Model?
by Tanuka De
LMND's AI-driven model is cutting costs, boosting retention and laying the groundwork for scalable, tech-led growth.
insurance
GL Stock Near 52-Week High: A Signal for Investors to Hold Tight?
by Zacks Equity Research
Globe Life is set to grow on rising premiums, rising investment income, and disciplined capital deployment.
insurance
Here's Why RenaissanceRe Shares Are Attracting Prudent Investors Now
by Zacks Equity Research
RNR shares are up 10% in six months as rising premiums, investment income and strategic deals strengthen its growth outlook.
finance insurance